PARAMOUNT: Final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer

1. Paz-Ares, L.G.
2. De Marinis, F.
3. Dediu, M.
4. Thomas, M.
5. Pujol, J.-L.
6. Bidoli, P.
7. Molinier, O.
8. Sahoo, T.P.
9. Laack, E.
10. Reck, M.
11. Corral, J.
12. Melemed, S.
13. John, W.
14. Chouaki, N.
15. Zimmermann, A.H.
16. Visseren-Grul, C.
17. Gridelli, C.